Previous studies reported that Acrp30 and leptin exhibit antagonizing effects in hepatocellular carcinoma [28]; thus, we have analyzed in our cell model system the effects of leptin treatment itself or in combination with Acrp30. This evidence concerns the gene ADIPOQ and hepatocellular carcinoma.